{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:03:03Z","timestamp":1770836583605,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T00:00:00Z","timestamp":1232409600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1038\/sj.bjc.6604885","type":"journal-article","created":{"date-parts":[[2009,1,20]],"date-time":"2009-01-20T21:08:51Z","timestamp":1232485731000},"page":"487-493","source":"Crossref","is-referenced-by-count":129,"title":["Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients"],"prefix":"10.1038","volume":"100","author":[{"given":"J D","family":"Barros-Silva","sequence":"first","affiliation":[]},{"given":"D","family":"Leit\u00e3o","sequence":"additional","affiliation":[]},{"given":"L","family":"Afonso","sequence":"additional","affiliation":[]},{"given":"J","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"M","family":"Dinis-Ribeiro","sequence":"additional","affiliation":[]},{"given":"M","family":"Fragoso","sequence":"additional","affiliation":[]},{"given":"M J","family":"Bento","sequence":"additional","affiliation":[]},{"given":"L","family":"Santos","sequence":"additional","affiliation":[]},{"given":"P","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"S","family":"R\u00eago","sequence":"additional","affiliation":[]},{"given":"C","family":"Brand\u00e3o","sequence":"additional","affiliation":[]},{"given":"F","family":"Carneiro","sequence":"additional","affiliation":[]},{"given":"C","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"F","family":"Schmitt","sequence":"additional","affiliation":[]},{"given":"M R","family":"Teixeira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,1,20]]},"reference":[{"key":"BF6604885_CR1","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1126\/science.3012781","volume":"232","author":"T Akiyama","year":"1986","unstructured":"Akiyama T, Sudo C, Ogawara H, Toyoshima K, Yamamoto T (1986) The product of the human c-erbB-2 gene: a 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232: 1644\u20131646","journal-title":"Science"},{"key":"BF6604885_CR2","first-page":"3845","volume":"54","author":"KF Becker","year":"1994","unstructured":"Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H (1994) E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845\u20133852","journal-title":"Cancer Res"},{"key":"BF6604885_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0968-6053(97)80008-7","volume":"4","author":"F Carneiro","year":"1997","unstructured":"Carneiro F (1997) Classification of gastric carcinomas. Curr Diag Pathol 4: 51\u201359","journal-title":"Curr Diag Pathol"},{"key":"BF6604885_CR4","first-page":"283","volume":"28","author":"B Carvalho","year":"2006","unstructured":"Carvalho B, Buffart TE, Reis RM, Mons T, Moutinho C, Silva P, van Grieken NC, Grabsch H, Van de Velde CJ, Ylstra B, Meijer GA, Carneiro F (2006) Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components. Cell Oncol 28: 283\u2013294","journal-title":"Cell Oncol"},{"key":"BF6604885_CR5","first-page":"27","volume":"79","author":"M Cimerman","year":"1994","unstructured":"Cimerman M, Repse S, Jelenc F, Omejc M, Bitenc M, Lamovec J (1994) Comparison of Lauren's, Ming's and WHO histological classifications of gastric cancer as a prognostic factor for operated patients. Int Surg 79: 27\u201332","journal-title":"Int Surg"},{"key":"BF6604885_CR6","first-page":"81","volume":"4","author":"JA Cohen","year":"1989","unstructured":"Cohen JA, Weiner DB, More KF, Kokai Y, Williams WV, Maguire Jr HC, LiVolsi VA, Greene MI (1989) Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract. Oncogene 4: 81\u201388","journal-title":"Oncogene"},{"key":"BF6604885_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0046-8177(90)90234-V","volume":"21","author":"K Davessar","year":"1990","unstructured":"Davessar K, Pezzullo JC, Kessimian N, Hale JH, Jauregui HO (1990) Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications. Hum Pathol 21: 325\u2013332","journal-title":"Hum Pathol"},{"key":"BF6604885_CR8","first-page":"384","volume":"5","author":"L David","year":"1992","unstructured":"David L, Seruca R, Nesland JM, Soares P, Sansonetty F, Holm R, Borresen AL, Sobrinho-Simoes M (1992) c-erbB-2 expression in primary gastric carcinomas and their metastases. Mod Pathol 5: 384\u2013390","journal-title":"Mod Pathol"},{"key":"BF6604885_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/path.1313","volume":"199","author":"M Dowsett","year":"2003","unstructured":"Dowsett M, Bartlett J, Ellis IO, Salter J, Hills M, Mallon E, Watters AD, Cooke T, Paish C, Wencyk PM, Pinder SE (2003) Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol 199: 418\u2013423","journal-title":"J Pathol"},{"key":"BF6604885_CR10","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/S0959-8049(99)00076-3","volume":"35","author":"CC Earle","year":"1999","unstructured":"Earle CC, Maroun JA (1999) Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35: 1059\u20131064","journal-title":"Eur J Cancer"},{"key":"BF6604885_CR11","first-page":"1178","volume":"12","author":"L Gianni","year":"2001","unstructured":"Gianni L, Panzini I, Tassinari D, Mianulli AM, Desiderio F, Ravaioli A (2001) Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol 12: 1178\u20131180","journal-title":"Ann Oncol"},{"key":"BF6604885_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/79120","volume":"26","author":"WM Grady","year":"2000","unstructured":"Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S (2000) Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet 26: 16\u201317","journal-title":"Nat Genet"},{"key":"BF6604885_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/00000421-200202000-00018","volume":"25","author":"D Green","year":"2002","unstructured":"Green D, Ponce DL, Leon-Rodriguez E, Sosa-Sanchez R (2002) Adenocarcinoma of the stomach: univariate and multivariate analysis of factors associated with survival. Am J Clin Oncol 25: 84\u201389","journal-title":"Am J Clin Oncol"},{"key":"BF6604885_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S1091-255X(98)80002-4","volume":"2","author":"LE Harrison","year":"1998","unstructured":"Harrison LE, Karpeh MS, Brennan MF (1998) Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer. J Gastrointest Surg 2: 126\u2013131","journal-title":"J Gastrointest Surg"},{"key":"BF6604885_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1200\/JCO.1993.11.8.1441","volume":"11","author":"J Hermans","year":"1993","unstructured":"Hermans J, Bonenkamp JJ, Boon MC, Bunt AM, Ohyama S, Sasako M, Van de Velde CJ (1993) Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 11: 1441\u20131447","journal-title":"J Clin Oncol"},{"key":"BF6604885_CR16","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/modpathol.3880350","volume":"14","author":"N Hirashima","year":"2001","unstructured":"Hirashima N, Takahashi W, Yoshii S, Yamane T, Ooi A (2001) Protein overexpression and gene amplification of c-erb B-2 in pulmonary carcinomas: a comparative immunohistochemical and fluorescence in situ hybridization study. Mod Pathol 14: 556\u2013562","journal-title":"Mod Pathol"},{"key":"BF6604885_CR17","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3748\/wjg.v8.i6.1023","volume":"8","author":"JK Hu","year":"2002","unstructured":"Hu JK, Chen ZX, Zhou ZG, Zhang B, Tian J, Chen JP, Wang L, Wang CH, Chen HY, Li YP (2002) Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. World J Gastroenterol 8: 1023\u20131028","journal-title":"World J Gastroenterol"},{"key":"BF6604885_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/11024150201680005","volume":"168","author":"KG Janunger","year":"2002","unstructured":"Janunger KG, Hafstrom L, Glimelius B (2002) Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 168: 597\u2013608","journal-title":"Eur J Surg"},{"key":"BF6604885_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/02841860151116385","volume":"40","author":"KG Janunger","year":"2001","unstructured":"Janunger KG, Hafstrom L, Nygren P, Glimelius B (2001) A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 40: 309\u2013326","journal-title":"Acta Oncol"},{"key":"BF6604885_CR20","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.humpath.2007.02.005","volume":"38","author":"MA Kim","year":"2007","unstructured":"Kim MA, Jung EJ, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH (2007) Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction. Hum Pathol 38: 1386\u20131393","journal-title":"Hum Pathol"},{"key":"BF6604885_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00428-004-1048-7","volume":"445","author":"M Kimura","year":"2004","unstructured":"Kimura M, Tsuda H, Morita D, Ichikura T, Ogata S, Aida S, Yoshizumi Y, Maehara T, Mochizuki H, Matsubara O (2004) A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements. Virchows Arch 445: 255\u2013262","journal-title":"Virchows Arch"},{"key":"BF6604885_CR22","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1007\/s00268-005-7795-z","volume":"29","author":"T Luebke","year":"2005","unstructured":"Luebke T, Baldus SE, Grass G, Bollschweiler E, Thiele J, Dienes HP, Hoelscher AH, Moenig SP (2005) Histological grading in gastric cancer by Ming classification: correlation with histopathological subtypes, metastasis, and prognosis. World J Surg 29: 1422\u20131427","journal-title":"World J Surg"},{"key":"BF6604885_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1023\/A:1008377101672","volume":"11","author":"E Mari","year":"2000","unstructured":"Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, Cascinu S, Barni S, Labianca R, Torri V (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell\u2019Apparato Digerente). Ann Oncol 11: 837\u2013843","journal-title":"Ann Oncol"},{"key":"BF6604885_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3816\/CBC.2005.n.026","volume":"6","author":"RD Mass","year":"2005","unstructured":"Mass RD, Press MF, Anderson S, Cobleigh MA, Vogel CL, Dybdal N, Leiberman G, Slamon DJ (2005) Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab. Clin Breast Cancer 6: 240\u2013246","journal-title":"Clin Breast Cancer"},{"key":"BF6604885_CR25","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1002\/1097-0142(19930615)71:12<3942::AID-CNCR2820711224>3.0.CO;2-3","volume":"71","author":"SJ McKenzie","year":"1993","unstructured":"McKenzie SJ, DeSombre KA, Bast BS, Hollis DR, Whitaker RS, Berchuck A, Boyer CM, Bast Jr RC (1993) Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer. Cancer 71: 3942\u20133946","journal-title":"Cancer"},{"key":"BF6604885_CR26","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1002\/1097-0142(197706)39:6<2475::AID-CNCR2820390626>3.0.CO;2-L","volume":"39","author":"SC Ming","year":"1977","unstructured":"Ming SC (1977) Gastric carcinoma. A pathobiological classification. Cancer 39: 2475\u20132485","journal-title":"Cancer"},{"key":"BF6604885_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0959-8049(99)00308-1","volume":"36","author":"S Msika","year":"2000","unstructured":"Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J (2000) Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer 36: 390\u2013396","journal-title":"Eur J Cancer"},{"key":"BF6604885_CR28","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<1894::AID-CNCR3>3.0.CO;2-J","volume":"85","author":"M Nakajima","year":"1999","unstructured":"Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H (1999) The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 85: 1894\u20131902","journal-title":"Cancer"},{"key":"BF6604885_CR29","first-page":"345","volume":"78","author":"A Ooi","year":"1998","unstructured":"Ooi A, Kobayashi M, Mai M, Nakanishi I (1998) Amplification of c-erbB2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization. Lab Invest 78: 345\u2013351","journal-title":"Lab Invest"},{"key":"BF6604885_CR30","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s10620-005-9057-1","volume":"51","author":"DI Park","year":"2006","unstructured":"Park DI, Yun JW, Park JH, Oh SJ, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Yoo CH, Son BH, Cho EY, Chae SW, Kim EJ, Sohn JH, Ryu SH, Sepulveda AR (2006) HER-2\/neu amplification is an independent prognostic factor in gastric cancer. Dig Dis Sci 51: 1371\u20131379","journal-title":"Dig Dis Sci"},{"key":"BF6604885_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"BF6604885_CR32","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1200\/JCO.2000.18.21.3651","volume":"18","author":"G Pauletti","year":"2000","unstructured":"Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R, Slamon DJ (2000) Assessment of methods for tissue-based detection of the HER-2\/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 18: 3651\u20133664","journal-title":"J Clin Oncol"},{"key":"BF6604885_CR33","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1038\/sj.onc.1202526","volume":"18","author":"M Pegram","year":"1999","unstructured":"Pegram M, Hsu S, Lewis G, Pietras R, Beryt M, Sliwkowski M, Coombs D, Baly D, Kabbinavar F, Slamon D (1999) Inhibitory effects of combinations of HER-2\/neu antibody and chemotherapeutic agents used for treatment of human breast cancers. Oncogene 18: 2241\u20132251","journal-title":"Oncogene"},{"key":"BF6604885_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/sj.onc.1201222","volume":"15","author":"MD Pegram","year":"1997","unstructured":"Pegram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ, Slamon DJ (1997) The effect of HER-2\/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells. Oncogene 15: 537\u2013547","journal-title":"Oncogene"},{"key":"BF6604885_CR35","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1056\/NEJMoa052306","volume":"353","author":"MJ Piccart-Gebhart","year":"2005","unstructured":"Piccart-Gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Lang I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Ruschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353: 1659\u20131672","journal-title":"N Engl J Med"},{"key":"BF6604885_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0888-7543(89)90343-1","volume":"4","author":"NC Popescu","year":"1989","unstructured":"Popescu NC, King CR, Kraus MH (1989) Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32. Genomics 4: 362\u2013366","journal-title":"Genomics"},{"key":"BF6604885_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10120-005-0342-7","volume":"8","author":"C Rebischung","year":"2005","unstructured":"Rebischung C, Barnoud R, Stefani L, Faucheron JL, Mousseau M (2005) The effectiveness of trastuzumab (herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein. Gastric Cancer 8: 249\u2013252","journal-title":"Gastric Cancer"},{"key":"BF6604885_CR38","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMoa052122","volume":"353","author":"EH Romond","year":"2005","unstructured":"Romond EH, Perez EA, Bryant J, Suman VJ, Geyer Jr CE, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353: 1673\u20131684","journal-title":"N Engl J Med"},{"key":"BF6604885_CR39","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"DJ Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A (1989) Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707\u2013712","journal-title":"Science"},{"key":"BF6604885_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344: 783\u2013792","journal-title":"N Engl J Med"},{"key":"BF6604885_CR41","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ijc.10257","volume":"98","author":"T Takehana","year":"2002","unstructured":"Takehana T, Kunitomo K, Kono K, Kitahara F, Iizuka H, Matsumoto Y, Fujino MA, Ooi A (2002) Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay. Int J Cancer 98: 833\u2013837","journal-title":"Int J Cancer"},{"key":"BF6604885_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/annonc\/mdi064","volume":"16","author":"M Tanner","year":"2005","unstructured":"Tanner M, Hollmen M, Junttila TT, Kapanen AI, Tommola S, Soini Y, Helin H, Salo J, Joensuu H, Sihvo E, Elenius K, Isola J (2005) Amplification of HER-2 in gastric carcinoma: association with topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab. Ann Oncol 16: 273\u2013278","journal-title":"Ann Oncol"},{"key":"BF6604885_CR43","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ijc.20001","volume":"109","author":"A Varis","year":"2004","unstructured":"Varis A, Zaika A, Puolakkainen P, Nagy B, Madrigal I, Kokkola A, Vayrynen A, Karkkainen P, Moskaluk C, El Rifai W, Knuutila S (2004) Coamplified and overexpressed genes at ERBB2 locus in gastric cancer. Int J Cancer 109: 548\u2013553","journal-title":"Int J Cancer"},{"key":"BF6604885_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/msb4100094","volume":"2","author":"A Wolf-Yadlin","year":"2006","unstructured":"Wolf-Yadlin A, Kumar N, Zhang Y, Hautaniemi S, Zaman M, Kim HD, Grantcharova V, Lauffenburger DA, White FM (2006) Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Mol Syst Biol 2: 54","journal-title":"Mol Syst Biol"},{"key":"BF6604885_CR45","doi-asserted-by":"publisher","first-page":"7308","DOI":"10.1073\/pnas.81.23.7308","volume":"81","author":"YH Xu","year":"1984","unstructured":"Xu YH, Richert N, Ito S, Merlino GT, Pastan I (1984) Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines. Proc Natl Acad Sci USA 81: 7308\u20137312","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6604885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604885","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6604885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:37:57Z","timestamp":1684413477000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6604885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,20]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["BF6604885"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6604885","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,20]]}}}